-
Genesio replaces Beye as Marseille boss
-
Thousands rush to get tickets for Bayeux Tapestry's UK show
-
Catholic society defies Vatican again by ordaining new bishops
-
Chinese firm sells hyper-real, 'always loyal' humanoid robots
-
Breakaway Catholic society defies Vatican again by ordaining bishops
-
World's oceans break June heat record: EU monitor
-
Venezuelans search, suffer one week after deadly quakes
-
China imposes 'national security' rules on overseas investments
-
Asian stocks mostly up as traders eye crucial US jobs data
-
'Nothing left except death': Myanmar families grieve huge war toll
-
Ronaldo and Modric struggle to defy Father Time at World Cup
-
England face DR Congo hurdle, USA prepare for World Cup moment in spotlight
-
The secret lives of Ukraine's deep-strike drone team
-
Myanmar mourns as post-coup conflict death toll hits 100,000
-
NATO project tests perennial grass to clean Ukraine's war-hit soil
-
Vietnam unveils 'baby bonus' after scrapping two-child policy
-
Duffy returns for New Zealand against West Indies
-
Majestic Olise raises France to another level at World Cup
-
Mbappe dazzles as France march on at World Cup; Norway, Mexico advance
-
Mexico see off Ecuador to break 40-year World Cup curse
-
US govt lifts restrictions on powerful AI models, Anthropic says
-
'My dream is broken': Japan visa rules push out foreign residents
-
Trump earned over $1 bn from crypto ventures in 2025
-
Indian sailors fear returning to Gulf after Middle East war
-
The Afghan women farmers keeping their village alive
-
Fear and anger brew inside Meta amid AI frenzy
-
Asian stocks fluctuate as traders eye crucial US jobs data
-
After 250 years, the 'American dream' is tarnished but alive
-
Madison Square Garden: from Nazis to Knicks, and now... Taylor's wedding?
-
'I'm going to stay calm': 48 hours under the rubble in Venezuela
-
'Love it': Wimbledon's military stewards tradition turns 80
-
Breakaway Catholic sect defies Vatican again by ordaining bishops
-
Venezuela quake survivors cherish kindness of strangers
-
Mexico v Ecuador World Cup game delayed by one hour: FIFA
-
US deports first migrant to Pacific nation Palau
-
Talks in Qatar after US-Iran deal: What we know
-
Potter admits Sweden couldn't live with France in World Cup defeat
-
Tuchel refuses to dampen England World Cup expectations
-
US coach dismisses European jinx ahead of Bosnia clash
-
Mbappe hails unity as France rally around Deschamps at World Cup
-
World Bank to phase out lending to China by 2031
-
Mbappe fires France into World Cup last 16, Norway advance
-
Mbappe scores twice as France breeze past Sweden into World Cup last 16
-
Belgium fully fit ahead of Senegal tie at World Cup, says Garcia
-
No corn dogs? Trump's 'Great American State Fair' threatens to be a flop
-
Tepid outlook weighs on Nike despite tariff refund boost
-
Haaland hailed as 'greatest' after more World Cup heroics
-
DR Congo have 'nothing to lose' in England World Cup clash
-
Koeman steps down as Netherlands coach after World Cup exit
-
Valiant Serena beaten on Wimbledon return, Swiatek survives scare
US panel weighs authorizing Covid vaccines for youngest children
After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.
Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.
Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."
Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.
Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.
They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.
Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.
But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.
There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.
White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.
Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.
Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.
Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.
Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."
E.Schubert--BTB